LP
DCPH

LMR Partners’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

LMR Partners’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-20,335
Closed -$376K – 1341
2022
Q3 		$376K Hold
20,335
– – 0.01% 927
2022
Q2 		$267K Sell
20,335
-106,000
-84% -$1.17M ﹤0.01% 1023
2022
Q1 		$1.17M Sell
126,335
-70,000
-36% -$595K 0.01% 752
2021
Q4 		$1.92M Buy
196,335
+145,000
+282% +$2.73M 0.02% 505
2021
Q3 		$1.74M Buy
+51,335
New +$1.64M 0.02% 496

Other funds holding DCPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wolverine Trading
Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

LMR Partners's DCPH Position: Q4 2022 in Review

LMR Partners sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2022, closing a stake of 20,335 shares — an estimated $376K sold.

LMR Partners first reported a position in DCPH in Q3 2021 and held it in 5 quarters. The position peaked at $1.92M in Q4 2021. 143 funds tracked by Wall St. Rank hold DCPH as of Q4 2022.

  • LMR Partners reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • LMR Partners sold 20,335 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2022, an estimated $376K.
  • LMR Partners first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2021 and held it in 5 quarters.
  • LMR Partners's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $1.92M in Q4 2021.
  • 143 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on LMR Partners's 13F filing for Q4 2022, filed 14 Feb 2023.